Reserve your spot today for the Specialty Pharmacy Satellite Dinner Symposium
Managed Care Review BoardTM - An Analysis of the Latest Treatments, Economic Value, and Benefit Designs for Multiple Myeloma
6:00 PM - 8:00 PM
Moscone West Convention Center
Room 3014-3016
San Francisco, CA
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting is required.
AMCP Managed Care & Specialty Pharmacy Annual Meeting.
Don't miss the free, on-demand CE primer for this activity!
www.ImpactEdu.net/MMPrimer
Register now for the live, free CE webcast series!
Webcast dates and times include:
| DAY | DATE | TIME |
| Tuesday | April 26 | 2:00 PM - 4:00 PM ET |
| Wednesday | May 18 | 12:00 PM - 2:00 PM ET |
| Thursday | May 19 | 1:00 PM - 3:00 PM ET |
| Tuesday | May 24 | 2:00 PM - 4:00 PM ET |
| Monday | July 11 | 12:00 PM - 2:00 PM ET |
www.ImpactEdu.net/MMWeb16
- Assessing the clinical benefits of multiple myeloma therapies in a managed care setting
- Current practice guidelines review
- Pharmacoeconomic assessment of current and emerging treatment options
- Maximizing value with plan benefit designs and specialty pharmacy services for current and emerging multiple myeloma therapies
|
Diana Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy University of Utah College of Pharmacy Executive Director, Outcomes Research Center Director of Outcomes, Program in Personalized Health Care University of Utah Health Sciences Center |
|
Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx Pharmacy Services, LLC |
|
John Fox, MD, MHA Senior Medical Director Associate Vice President, Medical Affairs Priority Health |
|
Shaji Kumar, MD Professor of Medicine Division of Hematology Mayo Clinic |
This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Managed Care & Specialty Pharmacy Annual Meeting.
The treatment paradigm for multiple myeloma (MM) is complex and evolving in light of both the continual introduction of novel agents and regimens, and enhanced patient profiling information. The expanding therapeutic armamentarium presents managed care and specialty pharmacy professionals with the challenge of understanding therapeutic efficacy and tolerability nuances, determining appropriate treatment sequencing and combinations, and evaluating access, coverage, and reimbursement decisions. This specialty pharmacy satellite symposium is designed to provide managed care and specialty pharmacy professionals the means by which collaborative care efforts may be implemented and provider support may be generated in conjunction with initiatives such as clinical pathways and comprehensive patient management programs.
The Managed Care Review BoardTM format features multi-specialty, multi-professional managed care, and clinical specialist faculty who collaborate on the review of the clinical data, current guidelines, and economic data of a specific class of therapeutics. It uniquely provides the audience with a review of important, relevant therapeutic category information and features peer-to-peer exchange between a diverse group of managed care and clinical specialist faculty contributors. This interactive program is designed to engage the faculty and audience to develop solutions for managed care and specialty pharmacy professionals to implement within their own setting to improve outcomes for patients with MM. This approach supports managed care pharmacists by enhancing the results of their own health care organization's systematic literature reviews and analyses.
At the conclusion of this activity, participants should be able to demonstrate improved ability to:
- Evaluate recent clinical data affecting evidence-based treatment guidelines for MM
- Demonstrate the value of clinical pathways initiatives as a means of reducing treatment variability and improving clinical and economic outcomes in the management of MM
- Implement comprehensive care strategies involving effective communication methods
- Integrate innovative oncology pharmacy benefit models with specialty pharmacy management services
- Provide accurate and appropriate counsel as part of the managed care treatment team
Date and Time
Tuesday, April 19, 2016
6:00 PM - 8:00 PM
Moscone West Convention Center
Room 3014-3016
San Francisco, CA
| 6:00 PM | Dinner and Registration |
| 6:05 PM |
Pre-Activity Learning Assessment and Opening Comments |
| 6:10 PM |
Evolving Treatment Options and Clinical Benefits Update in MM
Shaji Kumar, MD |
| 6:35 PM |
Current Practice Guidelines Review and Application of Clinical Pathways John Fox, MD, MHA |
| 6:55 PM |
Faculty Idea Exchange Faculty Panel |
| 7:00 PM |
Analyzing the Available Data to Assess the Value of MM Treatment Options Diana Brixner, RPh, PhD, FAMCP |
| 7:20 PM |
Plan Benefit Designs and Specialty Pharmacy Considerations in MM Jeffrey Dunn, PharmD, MBA |
| 7:40 PM |
Faculty Idea Exchange Faculty Panel |
| 7:45 PM |
Audience Q&A, Closing Commentary, and
Post-Activity Assessment and Evaluation
|
| 8:00 PM | Adjournment |
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
 |
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. |
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - (0809-9999-16-128-L01-P)
Type of Activity: Application
For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.
Fee Information
No additional fee is required to attend this CPE/CME activity.
Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting is required.
Pre-registration will close at 12:00 pm on April 18, 2016.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.